NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+4.17%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.5B
AUM Growth
+$1.5B
(-3.2%)
Cap. Flow
-$64.2M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
32.63%
Holding
124
New
18
Increased
34
Reduced
22
Closed
15
Top Buys
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$34.7M |
| 2 |
FirstCash
FCFS
|
$24.7M |
| 3 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
$21.7M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$19.8M |
| 5 |
TA
TravelCenters of America LLC
TA
|
$18.8M |
Top Sells
| 1 |
RH
RH
|
$39.3M |
| 2 |
Medifast
MED
|
$37.9M |
| 3 |
Tenet Healthcare
THC
|
$35.9M |
| 4 |
HCA Healthcare
HCA
|
$30.6M |
| 5 |
Adicet Bio
ACET
|
$29.6M |
Sector Composition
| 1 | Healthcare | 39.1% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Industrials | 10.41% |
| 4 | Technology | 9.82% |
| 5 | Financials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Codexis
CDXS
$246M
| $63M | 1.93% | 5,363,484 | – | – |
|
2
Dolby
DLB
$6.87B
| $62.2M | 1.9% | 938,656 +8,463 | +0.9% | +$561K |
|
3
uniQure
QURE
$896M
| $58.3M | 1.78% | 1,583,358 +15,209 | +1% | +$560K |
|
|
VG
4
DELISTED
Vonage Holdings Corporation
VG
| $53M | 1.62% | 5,183,712 +50,412 | +1% | +$516K |
|
|
QADA
5
DELISTED
QAD Inc.
QADA
| $50M | 1.53% | 1,184,365 +10,497 | +0.9% | +$443K |
|
6
Marriott Vacations Worldwide
VAC
$2.7B
| $47.9M | 1.47% | 527,683 -13,950 | -3% | -$1.27M |
|
|
APTO
7
DELISTED
Aptose Biosciences, Inc.
APTO
| $41.3M | 1.26% | 6,889,157 +912,305 | +15% | +$5.47M |
|
8
Travel + Leisure Co
TNL
$4.11B
| $40.1M | 1.23% | 1,304,435 +310,496 | +31% | +$9.55M |
|
|
TFFP
9
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $37.5M | 1.15% | 2,032,988 +1,176,471 | +137% | +$21.7M |
|
10
Establishment Labs
ESTA
$1.2B
| $35.6M | 1.09% | 1,919,190 +11,477 | +0.6% | +$213K |
|
11
Cue Biopharma
CUE
$60M
| $35.3M | 1.08% | 2,342,216 +16,828 | +0.7% | +$253K |
|
|
BMY.RT
12
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $34.7M | 1.06% | +15,437,336 | New | +$34.7M |
|
13
Pathward Financial
CASH
$1.82B
| $34.6M | 1.06% | 1,799,727 | – | – |
|
14
International Money Express
IMXI
$430M
| $33.3M | 1.02% | 2,318,668 -594,022 | -20% | -$8.53M |
|
15
Fortress Biotech
FBIO
$76.8M
| $33.2M | 1.02% | 8,224,938 +3,800,000 | +86% | +$15.4M |
|
16
Golden Entertainment
GDEN
$651M
| $29.4M | 0.9% | 2,127,788 | – | – |
|
17
Luxfer Holdings
LXFR
$359M
| $28.6M | 0.87% | 2,277,665 +24,193 | +1% | +$304K |
|
18
Immatics
IMTX
$619M
| $27M | 0.82% | 2,622,164 +1,510,077 | +136% | +$15.5M |
|
|
TA
19
DELISTED
TravelCenters of America LLC
TA
| $25.4M | 0.78% | 1,298,740 +961,350 | +285% | +$18.8M |
|
|
20
FirstCash
FCFS
$6.53B
| $24.7M | 0.76% | +431,569 | New | +$24.7M |
|
21
DXP Enterprises
DXPE
$1.96B
| $24.2M | 0.74% | 1,500,559 -98,923 | -6% | -$1.6M |
|
22
The Bancorp
TBBK
$3.51B
| $22.7M | 0.69% | 2,623,939 | – | – |
|
23
World Acceptance Corp
WRLD
$934M
| $22.4M | 0.68% | 212,042 -158,427 | -43% | -$16.7M |
|
24
Spyre Therapeutics
SYRE
$996M
| $22.1M | 0.68% | 3,123,430 -81,400 | -3% | -$577K |
|
25
Wave Life Sciences
WVE
$1.53B
| $20.2M | 0.62% | 2,378,426 +630,747 | +36% | +$5.36M |
|